Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
27,17 USD | -2,09% | -3,72% | -35,51% |
Attività
Numero di dipendenti: 164
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 01/06/19 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 04/10/21 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ian Gourley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Maria Alba
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jennifer Moseley
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 24/08/20 |
Jay Stout
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/04/23 |
Chief Tech/Sci/R&D Officer | 66 | 01/06/21 | |
Chau Cheng
IRC | Investor Relations Contact | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 18/12/19 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 18/12/19 |
Douglas Hughes
BRD | Director/Board Member | 62 | 18/12/19 |
Atul Pande
BRD | Director/Board Member | 69 | 18/12/19 |
Frank Torti
CHM | Chairman | 45 | 18/12/19 |
Eric Venker
BRD | Director/Board Member | 37 | 18/02/20 |
Peter Salzmann
CEO | Chief Executive Officer | 56 | 01/06/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 145 292 970 | 62 278 831 ( 42,86 %) | 0 | 42,86 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-35,51% | 3,95 Mrd | |
+1,51% | 42,75 Mrd | |
+8,57% | 41,34 Mrd | |
+49,22% | 41,61 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione IMVT
- Società Immunovant, Inc.